NO891471L - Fremgangsmaate for fremstilling av spirocykliske forbindelser innbefattende fem-leddede ringer med to heteroatomer. - Google Patents

Fremgangsmaate for fremstilling av spirocykliske forbindelser innbefattende fem-leddede ringer med to heteroatomer.

Info

Publication number
NO891471L
NO891471L NO89891471A NO891471A NO891471L NO 891471 L NO891471 L NO 891471L NO 89891471 A NO89891471 A NO 89891471A NO 891471 A NO891471 A NO 891471A NO 891471 L NO891471 L NO 891471L
Authority
NO
Norway
Prior art keywords
preparation
represents hydrogen
alkyl
heteratomes
procedure
Prior art date
Application number
NO89891471A
Other languages
English (en)
Norwegian (no)
Other versions
NO891471D0 (no
Inventor
Raymond Baker
Clare O Kneen
John Saunders
Christoper Swain
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO891471D0 publication Critical patent/NO891471D0/no
Publication of NO891471L publication Critical patent/NO891471L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Addiction (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Luminescent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO89891471A 1988-04-11 1989-04-10 Fremgangsmaate for fremstilling av spirocykliske forbindelser innbefattende fem-leddede ringer med to heteroatomer. NO891471L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888808433A GB8808433D0 (en) 1988-04-11 1988-04-11 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO891471D0 NO891471D0 (no) 1989-04-10
NO891471L true NO891471L (no) 1989-10-12

Family

ID=10634939

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89891471A NO891471L (no) 1988-04-11 1989-04-10 Fremgangsmaate for fremstilling av spirocykliske forbindelser innbefattende fem-leddede ringer med to heteroatomer.

Country Status (17)

Country Link
US (1) US4940703A (da)
EP (1) EP0337547B1 (da)
JP (1) JPH01305092A (da)
KR (1) KR900016202A (da)
AT (1) ATE102205T1 (da)
AU (1) AU617785B2 (da)
DE (1) DE68913327T2 (da)
DK (1) DK170489A (da)
ES (1) ES2061933T3 (da)
FI (1) FI891584A7 (da)
GB (1) GB8808433D0 (da)
IE (1) IE891137L (da)
IL (1) IL89822A0 (da)
NO (1) NO891471L (da)
NZ (1) NZ228583A (da)
PT (1) PT90223B (da)
ZA (1) ZA892587B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053412A (en) * 1990-04-10 1991-10-01 Israel Institute For Biological Research Spiro nitrogen-bridged heterocyclic compounds
EP0445974A3 (en) * 1990-03-05 1992-04-29 Merck Sharp & Dohme Ltd. Spirocyclic antipsychotic agents
US5407938A (en) * 1990-04-10 1995-04-18 Israel Institute For Biological Research Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines)
IL97726A (en) * 1990-04-10 1994-12-29 Israel Inst Biolog Res Pharmaceutical compositions containing compounds with bridged and unbridged heterocyclic groups, spiro-connected with oxazoline and thiazoline groups, and some new such compounds
JPH05310732A (ja) * 1992-03-12 1993-11-22 Mitsubishi Kasei Corp シンノリン−3−カルボン酸誘導体
US5817679A (en) 1993-04-01 1998-10-06 University Of Virginia 7-Azabicyclo 2.2.1!-heptane and -heptene derivatives as cholinergic receptor ligands
US6060473A (en) * 1993-04-01 2000-05-09 Ucb S.A. - Dtb 7-azabicyclo[2.2.1]-heptane and -heptene derivatives as cholinergic receptor ligands
AU701227B2 (en) * 1993-09-10 1999-01-21 Cytomed, Inc Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
US6117889A (en) * 1994-04-01 2000-09-12 University Of Virginia 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and anti-inflammatory agents
CZ289512B6 (cs) * 1994-08-24 2002-02-13 Astra Aktiebolag Spiro-azabicyklické sloučeniny pouľitelné při terapii
CZ82698A3 (cs) * 1995-09-18 1998-08-12 Glaxo Group Limited Použití antagonistů 5-HT3 receptorů pro výrobu farmaceutického prostředku k léčení diskinese
US8309577B2 (en) 2008-04-23 2012-11-13 Bristol-Myers Squibb Company Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
US7863291B2 (en) 2008-04-23 2011-01-04 Bristol-Myers Squibb Company Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
US9034891B2 (en) 2009-01-26 2015-05-19 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
WO2010084499A2 (en) * 2009-01-26 2010-07-29 Israel Institute For Biological Research Bicyclic heterocyclic spiro compounds
EP2253316B1 (en) 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
RU2608458C2 (ru) 2009-05-20 2017-01-18 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Антагонисты серотониновых 5-нт3-рецепторов для применения при лечении вестибулярных нарушений с повреждениями
US8507516B2 (en) 2009-10-28 2013-08-13 Bristol-Myers Squibb Company Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
US8278320B2 (en) 2009-10-28 2012-10-02 Bristol-Myers Squibb Company Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
MX2012004560A (es) * 2009-10-29 2012-05-08 Bristol Myers Squibb Co Compuestos de quinuclidina como ligandos del receptor de acetilcolina nicotinico alfa-7.
WO2011137313A1 (en) 2010-04-30 2011-11-03 Bristol-Myers Squibb Company Aza-bicyclic amine n-oxide compounds as alpha-7 nicotinic acetylcholine receptor ligand pro-drugs
JP5714745B2 (ja) * 2014-04-28 2015-05-07 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company α7ニコチン性アセチルコリン受容体リガンドとしてのキヌクリジン化合物
WO2020180876A1 (en) * 2019-03-04 2020-09-10 Beth Israel Deaconess Medical Center, Inc. Orai channel inhibitors
US12441707B2 (en) 2019-12-30 2025-10-14 Tyra Biosciences, Inc. Indazole compounds
PE20240687A1 (es) 2020-12-30 2024-04-10 Tyra Biosciences Inc Compuestos de indazol como inhibidores de cinasas

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3646053A (en) * 1970-05-18 1972-02-29 American Cyanamid Co Certain-(2-amino-4-thiazolyl)indoles
JPS4917534B1 (da) * 1970-10-06 1974-05-01
GB1301254A (da) * 1971-07-08 1972-12-29
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
AT357555B (de) * 1975-11-11 1980-07-25 Mundipharma Ag Verfahren zum herstellen von neuen spiro-(1,3- dioxolan-4,3')chinuclidinen, ihren salzen und isomeren
IL48452A (en) * 1975-11-11 1979-07-25 Purdue Frederick Co Spiro (1,3-dioxolane-4,3') quinuclidines,their preparationand pharmaceutical compositions comprising them
US4342769A (en) * 1978-10-02 1982-08-03 Schering Corporation 2-[(Methylsulfinyl)acetyl]-3-heterocyclicindoles and derivatives thereof as immunosuppressants
US4203990A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal 2-substituted quinuclidines
EP0083566A1 (en) * 1980-04-10 1983-07-13 Sandoz Ag Isoxazolyl indoles
US4332804A (en) * 1981-03-23 1982-06-01 Syntex (U.S.A.) Inc. 9-[2-(3-Indolyl)ethyl]-1oxa-4,9-diazaspiro[5.5]undecan-3-ones
DE3218172A1 (de) * 1982-05-14 1983-11-17 Hoechst Ag, 6230 Frankfurt Polyalkyldiazaspirodecanderivate, verfahren zu ihrer herstellung und ihre verwendung als stabilisatoren
DE3504284A1 (de) * 1985-02-08 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach Spiro-dithiolane, ihre herstellung und verwendung
DE3501225A1 (de) * 1985-01-16 1986-07-24 Sandoz-Patent-GmbH, 7850 Lörrach Spirodioxolane, ihre herstellung und verwendung
DE3504286A1 (de) * 1985-02-08 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach Spiro-oxothiolane, ihre herstellung und verwendung
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
DE3789039T2 (de) * 1986-06-27 1994-06-09 Beecham Group Plc Verbrückte bicyclische N-heterocyclische Verbindungen.
NL8701682A (nl) * 1986-07-30 1988-02-16 Sandoz Ag Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
US4707484A (en) * 1986-11-25 1987-11-17 Hoffmann-La Roche Inc. Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
NZ227684A (en) * 1988-01-30 1991-07-26 Merck Sharp & Dohme Pyrazine, pyridazine, and pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
AU3263289A (en) 1989-10-12
DE68913327T2 (de) 1994-07-28
PT90223A (pt) 1989-11-10
AU617785B2 (en) 1991-12-05
FI891584A7 (fi) 1989-10-12
IE891137L (en) 1989-10-11
EP0337547B1 (en) 1994-03-02
ATE102205T1 (de) 1994-03-15
DK170489D0 (da) 1989-04-10
JPH01305092A (ja) 1989-12-08
FI891584A0 (fi) 1989-04-03
PT90223B (pt) 1994-07-29
NZ228583A (en) 1990-02-26
KR900016202A (ko) 1990-11-12
EP0337547A1 (en) 1989-10-18
NO891471D0 (no) 1989-04-10
GB8808433D0 (en) 1988-05-11
ZA892587B (en) 1990-03-28
DK170489A (da) 1989-10-12
ES2061933T3 (es) 1994-12-16
US4940703A (en) 1990-07-10
IL89822A0 (en) 1989-12-15
DE68913327D1 (de) 1994-04-07

Similar Documents

Publication Publication Date Title
NO891471L (no) Fremgangsmaate for fremstilling av spirocykliske forbindelser innbefattende fem-leddede ringer med to heteroatomer.
ATE85325T1 (de) Zyklische enolderivate, herstellung und anwendung.
MX9701292A (es) Compuestos espiro-azabiciclicos utiles en la terapia.
NO924929L (no) Farmasoeytisk aktive benzoquinazolinforbindelser
ES8800234A1 (es) Procedimiento para la obtencion de compuestos de b-lactama
NO996453L (no) Nye tricykliske forbindelser med mettede ringer, samt medisinske blandinger inneholdende forbindelsene
IE872588L (en) Compounds
AU534786B2 (en) 4-phenoxypiperidines
SE8505887D0 (sv) Indoler
ES8504191A1 (es) Procedimiento para la preparacion de derivados de b-carbolinas.
NO800724L (no) Fremgangsmaate til fremstilling peptider med ubiquitinlignende aktivitet
MY126743A (en) Aminoethylphenoxyacetic acid derivatives and agents for relieving pain and promoting the removal of calculi in urolithiasis
ATE55907T1 (de) Oktahydroindolizine brauchbar als analgetika.
ATE77950T1 (de) Octahydroindolizine analgesica und 7-ketozwischenprodukte.
HUP0105180A2 (hu) Eljárás 2-amino-4-klór-1,3,5-triazin-származékok előállítására
ES2009222A6 (es) Procedimiento de preparacion de una composicion para tratar los cabellos a base de derivados de alquilen-diamino-quinazolina.
EP0477829A3 (en) Microbiological process for the preparation of hydroxylated heterocyclic compounds
ES8601099A1 (es) Procedimiento para la preparacion de nuevos derivados de n-(metoxifenacil)-amina
ES2161892T3 (es) Derivados de indol como profarmacos de agonistas de los receptores afines a 5-ht1.
HUT56482A (en) Fungicidal compositions comprising n-(2-phenoxyethyl)-morpholine derivatives as active ingredient and process for producing the active ingredients